Background and objectives Oral contraceptive pills (OCPs) are commonly used for contraception, but their long-term effects on oxidative stress, lipid profiles, and liver function remain unclear. This study… read more.
Complications during pregnancy (or adverse pregnancy outcomes), like gestational diabetes and newly developed high blood pressure, act as nature’s stress test and may uncover an individual’s risk for heart… read more.
Hot flashes, mood swings, weight gain and insomnia are all signs of hormonal changes and symptoms of menopause, when a woman no longer has menstrual cycles. They can… read more.
Before 2017, abortions were generally performed as procedures in fewer than 100 hospitals and clinics mostly in urban centres, leading to delayed care, particularly for people living in rural… read more.
Women with ongoing urinary incontinence could avoid invasive bladder pressure tests, as new research shows that a range of non-invasive assessments work just as well in guiding treatment…. read more.
Emergency hormonal contraception (EHC) – the morning-after pill – is to be available, free of charge, from community pharmacies in England starting in October. This is part of… read more.
GSK plc announced that the FDA has approved Blujepa (gepotidacin) for the treatment of female adults (≥40 kg) and paediatric patients (≥12 years, ≥40 kg) with uncomplicated urinary… read more.
Women affected by premenstrual syndrome (PMS) appear to experience less intense and debilitating symptoms after taking placebo pills even when told they do not contain any active medication,… read more.
When Emily Rosenfeld was doing a fellowship in maternal-fetal medicine at Rutgers Robert Wood Johnson Medical School (RWJMS), she noticed that many patients were returning to the hospital for hypertension…. read more.
Multiple menopause symptoms can make women feel fatigued. Hot flashes, sleep problems, pain, and depression are just a few. A new study suggests that heavy or prolonged menstrual… read more.
The use of the anti-contraction (tocolytic) drug atosiban in cases of threatened premature birth after 30 weeks of pregnancy is not more effective than placebo at reducing poor… read more.
Women with gynecological disorders such as endometriosis or heavy or irregular periods could be at an elevated risk of heart disease and cerebrovascular disease, researchers report. The findings… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
